Home > News > Biophan Technologies CEO Michael Weiner to Present Company Strategy
September 14th, 2004
Biophan Technologies CEO Michael Weiner to Present Company Strategy
Abstract:
Michael Weiner, CEO of Biophan Technologies, Inc. a developer of next-generation biomedical technology, is slated to present an overview of the Company's strategy and extensive intellectual property portfolio to potential investors at Friedland Capital's "Undervalued Equities Conference" in New York City today, the Company has announced.
Source:
Businesswire
Bookmark:
| Related News Press |
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||